Graham Partners has acquired HemaSource, a supplier of medical disposables to blood therapy companies and a provider of medical production distribution to plasma collection centers. Outside of its own products, the company has access to more than 1,300 SKUs from leading medical products manufacturers. HemaSource had received about $13.5 million in February 2010 from a group of investors including Housatonic Partners and Search Funds.
Graham Partners’ investments are focused on businesses with advanced manufacturing technologies and innovative product development capabilities, generally with EBITDA between $5 million and $50 million. At the end of 2008, the firm identified the medical products industry as a targeted area of interest due to steady long-term growth rates within the industry; HemaSource's acquisition consequently checks off multiple investment criteria.